BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 3486634)

  • 21. [Compatibility and toxicity of methotrexate in the treatment of bone tumors].
    Pongracz N; Kelaridis T; Ritschl P
    Arzneimittelforschung; 1987 Apr; 37(4):456-60. PubMed ID: 3496891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma.
    Tsuchiya H; Tomita K; Mori Y; Asada N; Morinaga T; Kitano S; Yamamoto N
    Anticancer Res; 1998; 18(1B):657-66. PubMed ID: 9584049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acral erythema caused by high-dose methotrexate therapy in patients with osteogenic sarcoma.
    Postovsky S; Ben Arush MW
    Pediatr Hematol Oncol; 2005 Mar; 22(2):167-73. PubMed ID: 15805003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical observations on the use of high-dose methotrexate treatment in osteogenic sarcoma (author's transl)].
    Kotz R; Leber H; Ramach W; Arbes H; Wolf A
    Wien Klin Wochenschr; 1977 Jul; 89(14):474-9. PubMed ID: 70889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. No correlation between methotrexate serum level and histologic response in the pre-operative treatment of extremity osteosarcoma.
    Bacci G; Loro L; Longhi A; Bertoni F; Bacchini P; Versari M; Picci P; Serra M
    Anticancer Drugs; 2006 Apr; 17(4):411-5. PubMed ID: 16549998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methotrexate levels and outcome in osteosarcoma.
    Zelcer S; Kellick M; Wexler LH; Shi W; Sankaran M; Lo S; Healey J; Huvos AG; Meyers PA; Gorlick R
    Pediatr Blood Cancer; 2005 Jun; 44(7):638-42. PubMed ID: 15704189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.
    Goorin AM; Schwartzentruber DJ; Devidas M; Gebhardt MC; Ayala AG; Harris MB; Helman LJ; Grier HE; Link MP;
    J Clin Oncol; 2003 Apr; 21(8):1574-80. PubMed ID: 12697883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful desensitization to high-dose methotrexate after systemic anaphylaxis.
    Davis KA; Williams P; Walker JC
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):87-9. PubMed ID: 12546343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neoadjuvant chemotherapy for osteosarcoma].
    Guo W; Yang RL; Tang XD; Tang S; Li DS; Yang Y
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1186-90. PubMed ID: 15387981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of osteogenic sarcoma. II. Aggressive resection of pulmonary metastases.
    Rosenburg SA; Flye MW; Conkle D; Seipp CA; Levine AS; Simon RM
    Cancer Treat Rep; 1979 May; 63(5):753-6. PubMed ID: 287554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Significance of surgical adjuvant chemotherapy in osteosarcoma].
    Yamawaki S; Isu K; Ubayama Y; Goto M; Kobayash M; Ishii S; Usui M; Yagi T; Sasaki T
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1430-7. PubMed ID: 3496046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dose escalation with pharmacokinetics monitoring in methotrexate chemotherapy of osteosarcoma.
    Delepine N; Delepine G; Cornille H; Brion F; Arnaud P; Desbois JC
    Anticancer Res; 1995; 15(2):489-94. PubMed ID: 7763028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of severe side effects of high-dose methotrexate in osteosarcoma].
    Umeda T; Takada N; Hodaka E; Endoh F; Ishii T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):285-94. PubMed ID: 6582805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Spectral EEG analysis in children treated with high-dose methotrexate].
    Fujii Y; Hongo T; Horikoshi Y; Mizuno Y; Ichimura M; Sugie Y; Sugie H; Igarashi Y
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):659-67. PubMed ID: 3493731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant therapy for nonmetastatic osteogenic sarcoma: an evaluation of transfer factor versus combination chemotherapy.
    Gilchrist GS; Ivins JC; Ritts RE; Pritchard DJ; Taylor WF; Edmonson JM
    Cancer Treat Rep; 1978 Feb; 62(2):289-94. PubMed ID: 346219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative regional chemotherapy and rapid-fraction irradiation for sarcomas of the soft tissue and bone.
    Denton JW; Dunham WK; Salter M; Urist MM; Balch CM
    Surg Gynecol Obstet; 1984 Jun; 158(6):545-51. PubMed ID: 6587604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination chemotherapy for osteosarcoma.
    Pratt CB; Rivera G; Shanks E; Kumar AP; Green AA; George S
    Cancer Treat Rep; 1978 Feb; 62(2):251-7. PubMed ID: 346214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases.
    Bacci G; Longhi A; Forni C; Fabbri N; Briccoli A; Barbieri E; Mercuri M; Balladelli A; Ferrari S; Picci P
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):505-11. PubMed ID: 17118571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Toxicosis of high-dose methotrexate (HD-MTX) for osteosarcoma, cured with treatment by leucovorin (LV) rescue and hemoperfusion--a case report].
    Kobayashi H; Morita T; Hirata Y; Kato T; Okada Y; Sato T
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):475-8. PubMed ID: 10740644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of osteosarcoma in children with pre- and postoperative chemotherapy and block resection of the tumor].
    Covarrubias-Espinoza G; Goiricelaya-Asia JM; Vásquez-Bojórquez R; López-Cervantes G
    Bol Med Hosp Infant Mex; 1991 Mar; 48(3):159-63. PubMed ID: 2064745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.